A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study

Journal of the Formosan Medical Association

Volumn 103, Issue 8, 2004, Pages 618-623

  Lan, Joung Liang ^a,b,c   Chou, Show Jan ^c   Chen, Der Yuan ^b,c   Chen, Yi Hsing ^c   Hsieh, Tsu Yi ^c   Young Jr , Mariano ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d Wyeth Ayerst Asia Ltd   (Taiwan)

Author keywords

Drug combinations; Methotrexate; Rheumatoid arthritis; TNFR Fc fusion protein; Tumor necrosis factor

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLARITHROMYCIN; CORTICOSTEROID; ETANERCEPT; GANCICLOVIR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE;

ABDOMINAL PAIN; ACCIDENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRONCHIOLITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE ACTIVITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRY EYE; DYSPEPSIA; DYSPNEA; DYSURIA; ENZYME DEFECT; FEMALE; FEVER; HUMAN; HYPERTENSION; INJECTION SITE; INJECTION SITE REACTION; INSOMNIA; LUNG INFILTRATE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PAIN; PAIN ASSESSMENT; PHARYNGITIS; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RHINITIS; SCORING SYSTEM; STOMATITIS; TAIWAN; VIRUS PNEUMONIA; VISUAL ANALOG SCALE; XEROSTOMIA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 8344285150     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Schuna AA, Schmidt MJ, Pigarelli DW: Rheumatoid arthritis and the seronegative spondyloarthropathies. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: A pathophysiologic approach. 3rd ed. Stamford, CT: Appleton and Lange; 1997: 1717-33.
2. Breedveld FC, Dijkmans BAC: Differential therapy in early and late stages of rheumatoid arthritis. Curr Opin Rheumatol 1996; 8:226-9.
3. Albert DA, Aksentijevich S, Hurst S, et al: Modeling therapeutic strategies in rheumatoid arthritis: use of decision analysis and Markov models. J Rheumatol 2000;27:644-52.
4. Feldman M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
5. Murray KM, Dahl SL: Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR-Fc) in rheumatoid arthritis. Ann Pharmacother 1997;31:1335-8.
6. Moreland LW, Schiff NH, Baumgartner SW, et al: Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999;130:478-86.
7. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
8. Lovell DJ, Giannini EH, Reiff A, et al: Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342:763-9.
9. Genovese MC, Bathon JM, Martin RW, et al: Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443-50.
10. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Prevoo MLL, van't Hof MA, Kuper HH, et al: Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38: 44-8.
12. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
13. Van Leeuwen: Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin Rheumatol 1994;8: 531-52.
14. Felson DT, Anderson JJ, Boers M, et al: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
15. Moreland LW, Baumgartner SW, Schiff MH, et al: Treatment of rheumatoid arthritis with recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337: 141-7.